LILIA NIKOLAYEV: Open Payments
NPI 1952493132 · COCOA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,706 in 60 payments from 12 companies in 2025. Trend: 2023 $1,803 · 2024 $1,370 · 2025 $1,706
Food & beverage: $1,706
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $472 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $261 |
| Alkermes, Inc. | 7 | $241 |
| Otsuka America Pharmaceutical, Inc. | 3 | $166 |
| Teva Pharmaceuticals USA, Inc. | 6 | $125 |
| Vanda Pharmaceuticals Inc. | 3 | $109 |
| Neurocrine BioSciences, Inc. | 5 | $94 |
| Axsome Therapeutics, Inc. | 4 | $93 |
| Lundbeck LLC | 2 | $52 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $44 |
Products named: VRAYLAR, CAPLYTA, ARISTADA, REXULTI, AUSTEDO XR, FANAPT, INGREZZA, Auvelity.
Industry payments across FL — which companies pay providers there.
